790 related articles for article (PubMed ID: 34073834)
1. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
[TBL] [Abstract][Full Text] [Related]
2. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
[TBL] [Abstract][Full Text] [Related]
3. Acute Elevated Resistin Exacerbates Mitochondrial Damage and Aggravates Liver Steatosis Through AMPK/PGC-1α Signaling Pathway in Male NAFLD Mice.
Wen F; Shi Z; Liu X; Tan Y; Wei L; Zhu X; Zhang H; Zhu X; Meng X; Ji W; Yang M; Lu Z
Horm Metab Res; 2021 Feb; 53(2):132-144. PubMed ID: 33302316
[TBL] [Abstract][Full Text] [Related]
4. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2).
Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD
Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625
[TBL] [Abstract][Full Text] [Related]
5. Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation.
Weng SW; Wu JC; Shen FC; Chang YH; Su YJ; Lian WS; Tai MH; Su CH; Chuang JH; Lin TK; Liou CW; Chu TH; Kao YH; Wang FS; Wang PW
Diabetologia; 2023 May; 66(5):913-930. PubMed ID: 36692509
[TBL] [Abstract][Full Text] [Related]
6. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
[TBL] [Abstract][Full Text] [Related]
7. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway.
Yang Y; Qiu W; Xiao J; Sun J; Ren X; Jiang L
J Transl Med; 2024 Mar; 22(1):309. PubMed ID: 38532480
[TBL] [Abstract][Full Text] [Related]
8. Investigating dual inhibition of ACC and CD36 for the treatment of nonalcoholic fatty liver disease in mice.
Devereux CJ; Bayliss J; Keenan SN; Montgomery MK; Watt MJ
Am J Physiol Endocrinol Metab; 2023 Feb; 324(2):E187-E198. PubMed ID: 36629823
[TBL] [Abstract][Full Text] [Related]
9. [Sichuan Dark Tea-Based Medicated Dietary Formula Improves Obesity-Induced Renal Lipid Metabolism Disorder in Mice by Remodeling Gut Microbiota and Short-Chain Fatty Acid Metabolism].
Li H; Zhang L; Huang R; Ren Q; Guo F; Shi M; Yang L; Yu Y; Ma L; Fu P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1112-1120. PubMed ID: 38162058
[TBL] [Abstract][Full Text] [Related]
10. GPR40 deficiency is associated with hepatic FAT/CD36 upregulation, steatosis, inflammation, and cell injury in C57BL/6 mice.
Lu Z; Li Y; Syn WK; Li AJ; Ritter WS; Wank SA; Lopes-Virella MF; Huang Y
Am J Physiol Endocrinol Metab; 2021 Jan; 320(1):E30-E42. PubMed ID: 33103454
[TBL] [Abstract][Full Text] [Related]
11. Icariin Alleviates Nonalcoholic Fatty Liver Disease in Polycystic Ovary Syndrome by Improving Liver Fatty Acid Oxidation and Inhibiting Lipid Accumulation.
Hai Y; Zuo L; Wang M; Zhang R; Wang M; Ren L; Yang C; Wang J
Molecules; 2023 Jan; 28(2):. PubMed ID: 36677577
[TBL] [Abstract][Full Text] [Related]
12. Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers.
Kasper P; Breuer S; Hoffmann T; Vohlen C; Janoschek R; Schmitz L; Appel S; Fink G; Hünseler C; Quaas A; Demir M; Lang S; Steffen HM; Martin A; Schramm C; Bürger M; Mahabir E; Goeser T; Dötsch J; Hucklenbruch-Rother E; Bae-Gartz I
Cells; 2021 May; 10(5):. PubMed ID: 34069390
[TBL] [Abstract][Full Text] [Related]
13. Dexmedetomidine ameliorates high-fat diet-induced nonalcoholic fatty liver disease by targeting SCD1 in obesity mice.
Tao L; Guo X; Xu M; Wang Y; Xie W; Chen H; Ma M; Li X
Pharmacol Res Perspect; 2021 Feb; 9(1):e00700. PubMed ID: 33474802
[TBL] [Abstract][Full Text] [Related]
14. Cotadutide effect in liver and adipose tissue in obese mice.
Marcondes-de-Castro IA; Oliveira TF; Spezani R; Marinho TS; Cardoso LEM; Aguila MB; Mandarim-de-Lacerda CA
J Mol Endocrinol; 2023 Apr; 70(3):. PubMed ID: 36753306
[TBL] [Abstract][Full Text] [Related]
15. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
Lee DS; An TH; Kim H; Jung E; Kim G; Oh SY; Kim JS; Chun HJ; Jung J; Lee EW; Han BS; Han DH; Lee YH; Han TS; Hur K; Lee CH; Kim DS; Kim WK; Park JW; Koo SH; Seong JK; Lee SC; Kim H; Bae KH; Oh KJ
Diabetologia; 2023 May; 66(5):931-954. PubMed ID: 36759348
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a new barbituric acid derivative suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice.
Suk FM; Hsu FY; Hsu MH; Chiu WC; Fang CC; Chen TL; Liao YJ
Life Sci; 2024 Jan; 336():122327. PubMed ID: 38061536
[TBL] [Abstract][Full Text] [Related]
17.
Bae S; Lee YH; Lee J; Park J; Jun W
Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558538
[No Abstract] [Full Text] [Related]
18. Gallic acid impairs fructose-driven de novo lipogenesis and ameliorates hepatic steatosis via AMPK-dependent suppression of SREBP-1/ACC/FASN cascade.
Lu Y; Zhang C; Song Y; Chen L; Chen X; Zheng G; Yang Y; Cao P; Qiu Z
Eur J Pharmacol; 2023 Feb; 940():175457. PubMed ID: 36529278
[TBL] [Abstract][Full Text] [Related]
19. PRDX6 Promotes Fatty Acid Oxidation
Shen W; Yang L; Yang Y; Wang P; Tao X; Shen Y; Wang S; Shen Y
Antioxid Redox Signal; 2023 Jun; 38(16-18):1184-1200. PubMed ID: 36401357
[No Abstract] [Full Text] [Related]
20. Oleuropein-Rich Jasminum Grandiflorum Flower Extract Regulates the LKB1-PGC-1α Axis Related to the Attenuation of Hepatocellular Lipid Dysmetabolism.
Hou Y; Zhao X; Wang Y; Li Y; Chen C; Zhou X; Jin J; Ye J; Li D; Gan L; Wu R
Nutrients; 2023 Dec; 16(1):. PubMed ID: 38201888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
